Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

8 May 2013 11:00

RNS Number : 2291E
Savills PLC
08 May 2013
 



 

8 May 2013

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 20 Grosvenor Hill, Berkeley Square, London W1K 3HQ and provides the following Interim Management Statement (IMS) for the period to 8 May 2013.

 

During the first four months of the year Savills has traded as anticipated with strong growth in Asia, a robust performance from the newly combined UK businesses and a continued reduction in losses in Continental Europe. Our US business has also shown improved performance in comparison with the same period last year and Cordea Savills, the Group's investment management business, has traded in line with our expectations. As previously indicated, we expect that our trading result to date will result in a stronger first half performance than in 2012 with the full year outlook in line with our expectations.

 

To date trading across the Asia Pacific region has remained strong with substantial improvements year on year. Looking forward, as anticipated, the residential markets in Hong Kong are being significantly affected by the latest round of Government control measures implemented in March with volumes falling by circa 30%. The doubling of stamp duty on commercial transactions in Hong Kong has also reduced the aggregate value of transactions since its implementation. We anticipate that improvements in trading in other parts of the region, particularly Australia and Japan will help to mitigate the financial impact of reduced transactional volumes in Hong Kong.

 

London's attractions as an investment location remain firmly established and indeed potentially enhanced by fiscal and other control measures implemented in other markets. In the UK commercial market Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although the shortage of supply of investment stock has become apparent. The increasing interest of overseas investors in Prime Central London assets has resulted in more domestic investors looking to opportunities in the UK's principal regional cities. Whilst it is still too early to be definitive, if this trend continues, we expect to see some improvements in our regional UK business through the coming period.

 

The Prime Residential market in central London has continued to perform strongly with year on year increases in both volume and value. Outside London, although it is early in the selling season, we have seen some improvement in the volume of activity in the traditionally stronger regional markets evidenced by improved volumes of new stock, applicants and viewings.

 

Globally, our Consultancy business has experienced double digit revenue growth with particular strengths in Planning and Development consultancy. The Property Management business has continued to deliver a solid increase in revenue.

 

Following a year of strategic changes and operational developments undertaken in 2012, Cordea Savills is now focused on further growth initiatives in Europe and Asia.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer/Martha Walsh

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEANSPEANDEEF
Date   Source Headline
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice
30th Mar 20237:47 amRNSAdditional Listing
16th Mar 20237:00 amRNSFinal Results
14th Mar 20235:07 pmRNSHolding(s) in Company
13th Mar 202311:06 amRNSDirector/PDMR Shareholding
1st Mar 202310:00 amRNSTotal Voting Rights
16th Feb 202311:17 amRNSBlock listing Interim Review
13th Feb 20234:32 pmRNSDirector/PDMR Shareholding
23rd Jan 202312:45 pmRNSBlock listing Interim Review
12th Jan 20234:10 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSYear End Trading Update
15th Dec 202211:59 amRNSNon-Executive Director Appointment
13th Dec 20221:20 pmRNSDirector/PDMR Shareholding
2nd Dec 202211:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.